Former Axonics CEO Raymond Cohen joins Nalu Medical as Chairman, bringing extensive leadership experience to drive innovation in medical device technology and market expansion.
NeuroOne Medical Technologies announces $8.0M public offering, strengthening their position in developing innovative electrode technology for neurological conditions.
Discover Marvell's breakthrough in silicon photonics technology, revolutionizing AI network infrastructure with their innovative low-power light engine solution for rack-scale interconnects.
Restor3d secures $38M funding to expand their innovative 3D-printed medical device portfolio, advancing personalized healthcare solutions through cutting-edge manufacturing technology.
FerriSSDs introduces comprehensive cyber protection framework, enhancing data security and reliability for embedded storage solutions in critical applications.
ACT Expo 2025 showcases cutting-edge power electronics innovations driving the e-mobility revolution, featuring breakthrough solutions for electric vehicle technology.
FDA approves breakthrough device for hip protection, enhancing patient safety and recovery in orthopedic care with innovative technology and design.
Cardiac Dimensions unveils a revolutionary nitinol-based cardiac device, transforming heart treatment with innovative design and advanced technology for improved patient outcomes.
Innoblative receives FDA breakthrough device designation for innovative breast cancer treatment technology, promising improved outcomes and patient care options.
Comparative analysis of Industry 4.0 implementation across major economies, highlighting USA and China's rapid progress and examining Europe's adoption challenges.
Edwards Lifesciences achieves CE mark for Sapien M3, a groundbreaking mitral valve treatment, setting new standards in transcatheter heart valve technology and patient care.
Innovative medical device receives CE mark approval for glaucoma treatment, enhancing patient care with advanced technology and improved therapeutic outcomes.
